These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 24923351)
1. Neuroimaging correlates of pharmacological and psychological treatments for specific phobia. Linares IM; Chags MH; Machado-de-Sousa JP; Crippa JA; Hallak JE CNS Neurol Disord Drug Targets; 2014; 13(6):1021-5. PubMed ID: 24923351 [TBL] [Abstract][Full Text] [Related]
2. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361 [TBL] [Abstract][Full Text] [Related]
3. Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine. Hofmann SG; Pollack MH; Otto MW CNS Drug Rev; 2006; 12(3-4):208-17. PubMed ID: 17227287 [TBL] [Abstract][Full Text] [Related]
4. Augmentation of cognitive behavioral therapy with pharmacotherapy. Ganasen KA; Ipser JC; Stein DJ Psychiatr Clin North Am; 2010 Sep; 33(3):687-99. PubMed ID: 20599140 [TBL] [Abstract][Full Text] [Related]
5. D-cycloserine as adjunct to brief computerised CBT for spider fear: Effects on fear, behaviour, and cognitive biases. Kappelmann N; Suesse M; Steudte-Schmiedgen S; Kaldewaij R; Browning M; Michael T; Rinck M; Reinecke A J Behav Ther Exp Psychiatry; 2020 Sep; 68():101546. PubMed ID: 31951819 [TBL] [Abstract][Full Text] [Related]
7. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435 [TBL] [Abstract][Full Text] [Related]
8. D-cycloserine as an augmentation strategy for cognitive behavioral therapy for anxiety disorders: an update. Hofmann SG; Sawyer AT; Asnaani A Curr Pharm Des; 2012; 18(35):5659-62. PubMed ID: 22632472 [TBL] [Abstract][Full Text] [Related]
9. Enhancing exposure-based therapy from a translational research perspective. Hofmann SG Behav Res Ther; 2007 Sep; 45(9):1987-2001. PubMed ID: 17659253 [TBL] [Abstract][Full Text] [Related]
10. D-cycloserine augmentation of cognitive behavioral therapy for anxiety disorders: an update. Hofmann SG; Otto MW; Pollack MH; Smits JA Curr Psychiatry Rep; 2015 Jan; 17(1):532. PubMed ID: 25413638 [TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy. Norberg MM; Krystal JH; Tolin DF Biol Psychiatry; 2008 Jun; 63(12):1118-26. PubMed ID: 18313643 [TBL] [Abstract][Full Text] [Related]
12. Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale. Hofmann SG; Carpenter JK; Otto MW; Rosenfield D; Smits JA; Pollack MH Contemp Clin Trials; 2015 Jul; 43():223-30. PubMed ID: 26111923 [TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear. Guastella AJ; Dadds MR; Lovibond PF; Mitchell P; Richardson R J Psychiatr Res; 2007 Sep; 41(6):466-71. PubMed ID: 16828803 [TBL] [Abstract][Full Text] [Related]
14. D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder. Hofmann SG; Smits JA; Rosenfield D; Simon N; Otto MW; Meuret AE; Marques L; Fang A; Tart C; Pollack MH Am J Psychiatry; 2013 Jul; 170(7):751-8. PubMed ID: 23599046 [TBL] [Abstract][Full Text] [Related]
15. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial. Andersson E; Hedman E; Enander J; Radu Djurfeldt D; Ljótsson B; Cervenka S; Isung J; Svanborg C; Mataix-Cols D; Kaldo V; Andersson G; Lindefors N; Rück C JAMA Psychiatry; 2015 Jul; 72(7):659-67. PubMed ID: 25970252 [TBL] [Abstract][Full Text] [Related]
16. Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis. Rodrigues H; Figueira I; Lopes A; Gonçalves R; Mendlowicz MV; Coutinho ES; Ventura P PLoS One; 2014; 9(7):e93519. PubMed ID: 24991926 [TBL] [Abstract][Full Text] [Related]
17. Social phobia: an update on treatment. Jørstad-Stein EC; Heimberg RG Psychiatr Clin North Am; 2009 Sep; 32(3):641-63. PubMed ID: 19716995 [TBL] [Abstract][Full Text] [Related]
18. Neuroimaging in specific phobia disorder: a systematic review of the literature. Linares IM; Trzesniak C; Chagas MH; Hallak JE; Nardi AE; Crippa JA Braz J Psychiatry; 2012 Mar; 34(1):101-11. PubMed ID: 22392396 [TBL] [Abstract][Full Text] [Related]
19. An fMRI study examining effects of acute D-cycloserine during symptom provocation in spider phobia. Aupperle RL; Hale LR; Chambers RJ; Cain SE; Barth FX; Sharp SC; Denney DR; Savage CR CNS Spectr; 2009 Oct; 14(10):556-71. PubMed ID: 20095368 [TBL] [Abstract][Full Text] [Related]
20. Learn to forget: Does post-exposure administration of d-cycloserine enhance fear extinction in agoraphobia? Pyrkosch L; Mumm J; Alt I; Fehm L; Fydrich T; Plag J; Ströhle A J Psychiatr Res; 2018 Oct; 105():153-163. PubMed ID: 30237105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]